Magnesium for Postoperative Pain Management
Evidence-Based Dosing and Administration
- The American Society of Anesthesiologists recommends a standard dosing of 50 mg/kg IV bolus over 10 minutes after intubation, followed by 50 mg/kg/h continuous infusion until end of surgery, which reduces postoperative opioid consumption by approximately 24% and modestly improves pain scores without significant adverse effects 1, 2
- This regimen reduced 24-hour opioid demand from 44.7 mg to 35.1 mg morphine equivalents in video-assisted thoracoscopic surgery, with a moderate strength of evidence 1, 2
Alternative Routes and Contexts
- Neuraxial magnesium (75 mg epidural or intrathecal) prolongs sensory block duration, lowers pain scores, and reduces rescue analgesic requirements, with a high strength of evidence 3, 4
- Perineural magnesium (2 ml of 10% magnesium sulfate) reduces pain scores at 12 hours postoperatively in rotator cuff surgery, although the strength of evidence is low 5
- The World Society of Emergency Surgery guidelines recommend avoiding neuraxial administration of magnesium in emergency general surgery settings, due to the potential risk of adverse effects 6
Integration into Multimodal Analgesia
- The British Journal of Anaesthesia recommends a basic analgesia foundation of paracetamol and NSAIDs alongside magnesium, with a high strength of evidence 1, 2
- Magnesium works synergistically with lidocaine, ketamine, and dexmedetomidine in opioid-free or opioid-sparing protocols, with a moderate strength of evidence 8, 7
Procedure-Specific Applications
- Video-assisted thoracoscopic surgery: improved postoperative FEV1 and forced vital capacity in addition to analgesic benefits, with a high strength of evidence 1, 2
- Total hip arthroplasty: intrathecal or IV magnesium lowers pain scores and 24-hour morphine consumption, with a moderate strength of evidence 3
- Caesarean section: neuraxial magnesium demonstrates longer sensory block duration and reduced rescue analgesia requirements, with a high strength of evidence 4
- Bariatric surgery: recommended as part of multimodal opioid-sparing approach given increased opioid sensitivity in obesity, with a moderate strength of evidence 7
Safety Profile and Adverse Effects
- No clinical toxicity reported in meta-analyses when used at recommended doses, with a high strength of evidence 9
- Potential side effects: hypotension and prolongation of neuromuscular blockade are theoretical concerns but rarely clinically significant, with a low strength of evidence 9